b'TRANSFER EFFICACY STUDY \x03 AIONX makes no claims herein.See bottom for full legal disclaimer.E\x03^\x12\x03d\x03\x03 THIRD PARTY STUDY CHARACTERIZING UNIT-WIDE EFFICACY Regina Lamendella Ph.D, Justin R. Wright, Alexander J. Shope MD.\x03 Contamination Source Identification, LLC, Huntingdon, PA \x03CleanSURFACES\x03\x03\x03\x03\x03\x03\x03\x03\x03\x03\x03\x03\x03\x03A third party recently explored the impact on an ICUs contamination transmission network of strategic use of cleanSURFACES. The researchers found \x03 \x03\x03\x03\x03\x03d\x03\x03\x03\x03\x03\x03 that use of cleanSURFACES on several surfaces with high impact in the contamination transmission network eliminated or significantly reducedbacterial species (including in spore form) not only on surfaces protected by the product but also on many high touch surfaces NOT covered with \x03\x03\x03\x03\x03\x03\x03\x03\x03\x03\x03\x03 the products. Many key species were among those impacted by the intervention on all sampled surfaces.\x03 \x03\x03 \x03\x12^hZ&\x04\x12\x1c^dD \x03\x03\x03 \x03 \x03d\x03\x03\x03\x03 CleanSURFACES\x03\x03\x03 STUDY DESIGN^\x03\x03\x03\x03\x03\x03 \x03\x03\x1cW\x04\x03Z\x03E\x03\x03\x03\x03\x03\x03\x03\x03 \x03\x03\x03 \x03 \x03 \x03 \x03 Pre-InterventionIntervention \x03 \x12\x03\x03\x03\x03\x03\x03\x03\x03\x03\x03\x03\x03\x03\x03 The following surfaces were sampled at 8 timecleanSURFACES were placed on the \x03 \x18\x03\x03\x03\x03\x03\x03\x03\x03 \x03 \x03 \x03 \x03 \x03 points to determine baseline contamination: following surfaces: \x03 \x03\x03\x03 \x03\x03\x03\x03\x03\x03d\x03\x1cW\x04\x03\x03\x03\x03 \x03 Can be used as decontamination station to clean items laid on\x03\x03\x03\x03\x04/KEy\x03\x03\x03\x03\x03\x03 Central Nurse Station Each of 4 Patient RoomsCentral Nurse Station \x03 \x03 \x03\x03\x03\x03\x03\x03\x03Desk/work areaBed railsDesk work area \x03 \x1c\x03\x03\x03\x03 \x03 \x03\x03 cleanSURFACES covering the bed Supply door push plate Patient overbed table (OBT)Door push plate (supply room)Landline phoneNurse overbed table (OBT)Flat area of WOWrails, the WOW, and an overbed table \x03 in a patient room.dW\x03\x1c\x03\x18\x03 ID badgeIV pump controld\x03\x03\x03\x03\x03\x03\x03 \x03\x03\x03 Keyboard, nurse stationWOW keyboardEach of 4 Patient RoomsOrganism% ReductionLog ReductionTimeThird Party ResearcherMouse, nurse stationWOW mouseBed railsDesk chair railsS lPatient overbed table (OBT) Cellphone E. coli99.9999% 6 log 10 5 minutesAgile Sciences, Inc. (2014). Unpublished report.Nurse overbed table (OBT) Stethoscope Flat area of WOW MRSA99.9999% 6 log 10 10 minutesAgile Sciences, Inc. (2014). Unpublished report.GlucometerPost-InterventionWOW keyboard After a 13-day settle period, all surfaces originally sampled (even those not covered byCentral nurse station with H1N1 influenza virus99.998% 4.7 log 10 30 minutesMendenhall M. (2019). Unpublished report, products) were sampled again using the samecleanSURFACES covering the WOW and Utah State University.the nurse desk/work area.98%1.7 log 10 10 minutessampling protocol.Murine norovirus99.997% 4.5 log 10 30 minutesMendenhall M. (2019). Unpublished report, 93.7%1.2 log 10 10 minutesUtah State University.IMPACT ON C. DIFF C. diff spores97% 1.46 log 10 45 minutesCadnum J, Livingston S. (2018). Unpublished data,Pre-Intervention Post-InterventionCurtis Donskey Research Services. After a one-day stay, a patient with an active C. diff infection wasAfter an 11 day stay, a patient with an active C. diff infection was discharged (from Room 3 in the below chart) 6 days prior to the start ofdischarged from one of the rooms in the study 24 hours before the C. diff data generated using older-generation CleanSURFACES technology. Testing using current technology against C. diff spores is underway.swabbing. The following chart shows the surfaces on which C. diff wasstart of swabbing.Despite this, no C. diff was detected after the \x03 identified and the abundance of DNA sequences isolated.intervention of cleanSURFACES.\x18\x03\x03\x12\x03d\x03E\x03\x03 250 250 \x03 200 200\x03 CleanSURFACES\x03 \x18\x03 150 150\x03 \x03\x03 \x03\x03\x03\x03 \x03100 100\x03 \x03\x03 \x03\x03 50\x03 \x03\x03 \x03 50\x03 \x03\x03 \x03 0 0\x03 \x03\x03 \x03 \x03\x03\x03 No C. diff was detected on any of the sampled surfaces. Room 1Room 2Room 3Room 4Nurse Station \x03\x03AionX 23cleanSURFACESuse a technology registered with the EPA (Reg. No. 91681-1) as an antimicrobial agent that effectively inhibits the growth of bacteria, fungi, algae, mold, and mildew that cause unpleasant odors, discoloration, staining, deterioration or corrosion on surfaces to which it is applied. The EPA has not reviewed or approved, \x03 515 Rear West Chocolate Ave Hershey, PA 17033 make, any claims that its technology has efficacy against any particular pathogenic microbes. The use of cleanSURFACES is a supplement to and not a nor does AIONX888.512.4669 |firstname.lastname@example.org| aionx.comsubstitute for standard infection control practices.'